Serving hundreds of leading biopharmaceutical companies globally:

Generated: March 24, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CANAGLIFLOZIN

« Back to Dashboard

Clinical Trials for Canagliflozin

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00642278	An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 2	The purpose of this study is to evaluate the effectiveness, safety, and tolerability of JNJ-28431754 compared with placebo in patients with type 2 diabetes.
NCT00650806	A Study of the Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 2	The purpose of this study is to test the safety and effectiveness of JNJ-28431754 in promoting weight loss in patients who are overweight or obese and who do not have diabetes.
NCT00963768	A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 1	The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (ie, blood levels of JNJ-28431754) and pharmacodynamics (ie, urine and blood levels of glucose) of JNJ-28431754 compared to placebo in patients with Type 2 diabetes mellitus.
NCT00968812	CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride	Completed	Janssen Research & Development, LLC	Phase 3	The purpose of this study is to demonstrate the efficacy, safety, and tolerability of canagliflozin (JNJ-28431754) compared with glimepiride in patients with type 2 diabetes mellitus with inadequate control despite treatment with metformin.
Trial ID	Title	Status	Sponsor	Phase	Summary

Clinical Trial Conditions for Canagliflozin

Condition Name

Chart
Table

Condition Name for Canagliflozin
Intervention	Trials
Healthy	40
Diabetes Mellitus, Type 2	32
Type 2 Diabetes Mellitus	11
Healthy Volunteers	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Chart
Table

Condition MeSH for Canagliflozin
Intervention	Trials
Diabetes Mellitus	50
Diabetes Mellitus, Type 2	49
Overweight	4
Kidney Diseases	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Canagliflozin

Trials by Country

Map
Table

Trials by Country for Canagliflozin
Location	Trials
United States	506
Canada	60
Mexico	17
India	16
Germany	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Map
Table

Trials by US State for Canagliflozin
Location	Trials
Florida	28
California	27
Texas	24
Arizona	24
Louisiana	17
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Canagliflozin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Canagliflozin
Clinical Trial Phase	Trials
Phase 4	19
Phase 3	18
Phase 2	9
[disabled in preview]	55
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Chart
Table

Clinical Trial Status for Canagliflozin
Clinical Trial Phase	Trials
Completed	73
Recruiting	17
Not yet recruiting	9
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Canagliflozin

Sponsor Name

Chart
Table

Sponsor Name for Canagliflozin
Sponsor	Trials
Janssen Research & Development, LLC	40
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	31
Janssen Scientific Affairs, LLC	8
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Chart
Table

Sponsor Type for Canagliflozin
Sponsor	Trials
Industry	95
Other	28
NIH	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.